CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

Sponsored by Penumbra, Inc.

cit | Article | March/April 2020

Innovation in Coronary Mechanical Thrombectomy: Indigo® System CAT™ RX Powered by Penumbra ENGINE™

With S. Jay Mathews, MD, MS, FACC; Chris Metzger, MD; Waqas R. Qureshi, MD, MS; Jawairia Sahar K. Mirza, MBBS; Gus Theodos, MD, FACC, FSCAI; Brian Kolski, MD; and Suhail Dohad, MD, FACC

cit | News | February 5, 2013

IDE Study Begins for TherOx's Next-Generation Supersaturated Oxygen Therapy to Treat AMI

February 6, 2013—TherOx, Inc. (Irvine, CA) announced the initiation of a multicenter investigational device exemption (IDE) pilot study of the company's second-generation system that delivers supersaturated oxygen (SSO2) therapy to reduce infarct size after an acute myocardial infarction.

cit | News | January 28, 2025

AVS Raises Financing to Support Pulse IVL System Launch in the United States

January 28, 2025—Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (PIVL) platform for the treatment of severely calcified arterial disease, announced that it has completed a Series B round of financing of $36 million.

cit | Article | May/June 2018

Ask the Experts: Will Bioresorbable Scaffolds Ultimately Have a Role?

Experts discuss the outcomes of the ABSORB trials and what the future may hold for bioresorbable scaffolds.

With Dean J. Kereiakes, MD, FACC, FSCAI; Ron Waksman, MD, FACC, FSCAI, FESC; James B. Hermiller Jr, MD, FACC, MSCAI; and Jarrod D. Frizzell, MD, FACC, SCAI

Advertisement

Advertisement

cit | Article | May/June 2016

How Will New Bioresorbable Polymer Drug-Eluting Stents Impact DAPT Duration?

Current bioresorbable polymer, everolimus-eluting stent technology appears well suited for abbreviated-duration dual-antiplatelet therapy.

By Ian J. Sarembock, MBChB, MD, FACC, and Dean J. Kereiakes, MD, FACC


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button